What Makes This Product Unique Maximum Convenience - Non-rechargeable design means zero maintenance, no charging cables, and no hassle - just vape until empty and dispose responsibly Smooth 20mg (2%) Nicotine - Perfect nicotine strength for vapers seeking satisfaction without the intensity of higher concentrations 6.5ml / 2,000 Puffs - Extended usage capacity in a compact form factor for days of reliable performance Powerful 650mAh Battery - Built to last the entire lifetime of the device without performance degradation Premium Creamy Frostbite Flavor - Signature creamy mint blend that's smooth, refreshing, and perfectly balanced Draw-Activated Technology - No buttons, no adjustments, no learning curve - simply inhale and enjoy immediate satisfaction Key Benefits True Disposable Design - Use it straight from the package until empty, then dispose - no charging required Portable Lifestyle - Slim, lightweight design fits easily in pockets, purses, or bags for vaping anywhere Consistent Vapor Production - Engineered coil system maintains flavor quality from first puff to last Cost-Effective Solution - 6.5ml capacity delivers exceptional value per device, now on sale for just $14.95 Beginner-Friendly - Perfect for new vapers or anyone seeking hassle-free nicotine delivery at a comfortable strength Lower Nicotine Option - 20mg (2%) provides a smoother experience ideal for transitioning or reducing nicotine intake Flavor Profile The Loon Maxx 20mg features the signature Creamy Frostbite flavor at 20mg (2%) salt nicotine
Other Health Benefits Of Mint Beyond digestion, mint offers several other health benefits, thanks to its natural compounds, including menthol and antioxidants
Geruch: Der typisch Duft von Absinth steigt bei der Duftprobe in die Nase: intensiv und begleitet von Fenchel-Noten sowie einer dezenten Dosis Menthol
Scan J Urol 35 : 117121 Cho CH et al
Minimal ban: Smoke-free legislation covering health-care and educational facilities, as well as 1 or 2 other places and institutions
Retrieved from .int/tobacco/global_report/2011/exec_summary/en World Health Organization
